LRPA
LLY icon

L. Roy Papp & Associates’s Eli Lilly LLY Stock Holding History

L. Roy Papp & Associates’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.22M Buy
1,847
+330
+22% +$337K 0.23% 66
2026
Q1 		$1.4M Hold
1,517
– – 0.16% 85
2025
Q4 		$1.63M Sell
1,517
-497
-25% -$475K 0.18% 80
2025
Q3 		$1.54M Sell
2,014
-83
-4% -$61.8K 0.17% 79
2025
Q2 		$1.63M Sell
2,097
-22
-1% -$17.1K 0.19% 79
2025
Q1 		$1.75M Sell
2,119
-88
-4% -$73.2K 0.21% 71
2024
Q4 		$1.7M Sell
2,207
-8
-0.4% -$6.62K 0.2% 74
2024
Q3 		$1.96M Sell
2,215
-165
-7% -$148K 0.24% 70
2024
Q2 		$2.15M Sell
2,380
-48
-2% -$38.4K 0.26% 65
2024
Q1 		$1.89M Sell
2,428
-65
-3% -$46.3K 0.22% 72
2023
Q4 		$1.45M Buy
2,493
+10
+0.4% +$5.84K 0.18% 79
2023
Q3 		$1.33M Sell
2,483
-50
-2% -$25.8K 0.18% 77
2023
Q2 		$1.19M Sell
2,533
-164
-6% -$68.8K 0.15% 86
2023
Q1 		$926K Sell
2,697
-179
-6% -$60.4K 0.13% 100
2022
Q4 		$1.05M Hold
2,876
– – 0.15% 90
2022
Q3 		$930K Buy
2,876
+1,705
+146% +$540K 0.14% 92
2022
Q2 		$380K Hold
1,171
– – 0.06% 135
2022
Q1 		$335K Sell
1,171
-2
-0.2% -$515 0.04% 146
2021
Q4 		$324K Buy
1,173
+2
+0.2% +$507 0.04% 153
2021
Q3 		$271K Sell
1,171
-100
-8% -$24.7K 0.03% 158
2021
Q2 		$292K Hold
1,271
– – 0.04% 156
2021
Q1 		$237K Sell
1,271
-580
-31% -$113K 0.03% 157
2020
Q4 		$313K Buy
1,851
+79
+4% +$11.8K 0.04% 153
2020
Q3 		$262K Hold
1,772
– – 0.03% 152
2020
Q2 		$291K Buy
1,772
+125
+8% +$19.2K 0.04% 140
2020
Q1 		$228K Sell
1,647
-100
-6% -$13.7K 0.04% 140
2019
Q4 		$230K Buy
+1,747
New +$203K 0.03% 164
2019
Q3 		– Sell
-1,963
Closed -$217K – 176
2019
Q2 		$217K Hold
1,963
– – 0.03% 161
2019
Q1 		$255K Sell
1,963
-493
-20% -$59.9K 0.05% 137
2018
Q4 		$284K Sell
2,456
-350
-12% -$39.1K 0.06% 125
2018
Q3 		$301K Buy
2,806
+425
+18% +$42.5K 0.05% 131
2018
Q2 		$203K Buy
+2,381
New +$196K 0.04% 155
2018
Q1 		– Sell
-2,506
Closed -$212K – 159
2017
Q4 		$212K Buy
2,506
+25
+1% +$2.13K 0.04% 144
2017
Q3 		$212K Hold
2,481
– – 0.05% 126
2017
Q2 		$204K Hold
2,481
– – 0.04% 145
2017
Q1 		$209K Buy
+2,481
New +$199K 0.05% 133
2016
Q4 		– Sell
-2,631
Closed -$211K – 155
2016
Q3 		$211K Hold
2,631
– – 0.05% 143
2016
Q2 		$207K Buy
+2,631
New +$198K 0.05% 149
2016
Q1 		– Sell
-2,831
Closed -$239K – 150
2015
Q4 		$239K Hold
2,831
– – 0.06% 126
2015
Q3 		$237K Buy
+2,831
New +$239K 0.06% 129

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
GIM
Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

L. Roy Papp & Associates's LLY Position: Q2 2026 in Review

L. Roy Papp & Associates increased its Eli Lilly (LLY) stake by 22% in Q2 2026, buying an estimated $337K and bringing the position to 1,847 shares worth $2.22M. The position accounts for 0.23% of the portfolio, ranked #66.

L. Roy Papp & Associates first reported a position in LLY in Q3 2015 and has held it in 40 quarters since. 1,844 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • L. Roy Papp & Associates held 1,847 shares of Eli Lilly worth $2.22M as of Q2 2026.
  • L. Roy Papp & Associates bought 330 Eli Lilly shares in Q2 2026, an estimated $337K.
  • Eli Lilly made up 0.23% of L. Roy Papp & Associates's portfolio in Q2 2026, its #66 holding.
  • L. Roy Papp & Associates first reported a position in Eli Lilly in Q3 2015 and has held it in 40 quarters since.
  • 1,844 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on L. Roy Papp & Associates's 13F filing for Q2 2026, filed 23 Jul 2026.